BIOMARIN PHARMACEUTICAL INC 10-Q filing
Filed 2026-05-05 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001048477-26-000008
- Form type
- 10-Q
- CIK
- 0001048477
- Primary document
- https://www.sec.gov/Archives/edgar/data/1048477/000104847726000008/bmrn-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIOMARIN PHARMACEUTICAL INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $766.2M | - | - |
| Cost Of Revenue | $195.0M | - | - |
| Operating Income | $129.6M | - | - |
| Net Income | $105.5M | - | - |
| Eps Basic | 0.55 | - | - |
| Eps Diluted | 0.54 | - | - |
| Cash And Equivalents | $2.2B | - | - |
| Total Assets | $8.6B | - | - |
| Total Liabilities | $2.4B | - | - |
| Shareholders Equity | $6.2B | - | - |
| Operating Cash Flow | $220.7M | - | - |
| Capital Expenditures | $20.9M | - | - |